Friday 16 October 2026
Export TLSA’s income statement to Excel — free account
Tiziana Life Sciences Ltd
TLSA Healthcare Biotechnology
Insiders bought in the last twelve months.
1.06
0.01
+0.95%
Follow TLSA
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 | |
|---|---|---|---|---|---|---|---|---|---|---|
Current Ratio |
0.76 | 1.02 | 1.12 | 3.64 | 6.45 | 8.79 | 0.20 | 1.08 | 0.52 | 2.89 |
Net Debt/EBITDA |
0.19 | 0.24 | 0.07 | 1.25 | 1.55 | 2.34 | (0.10) | 0.48 | (0.03) | 0.55 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.46% | 48.60% | 8.31% | 17.31% | 5.51% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | (0.21) | 1.11 | (0.19) | 0.08 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.70 | 0.13 | 0.89 | 1.27 | 0.93 | 0.43 | 0.73 | 0.58 | 0.86 | 0.71 |
Capex/Depreciation |
(0.09) | (0.15) | 0.00 | 0.00 | (0.16) | (0.03) | (0.02) | 0.00 | (0.08) | (4.36) |
Interest Coverage |
21,132.00 | 19.40 | 15.72 | (2,083.71) | (155.53) | (89.83) | (109.02) | (822.25) | (884.67) | (823.25) |
| (924.32%) | (250.49%) | (140.92%) | (50.61%) | (45.18%) | (91.89%) | 373.29% | 902.10% | (963.09%) | 1,282.91% | |
| (161.82%) | (101.10%) | (91.52%) | (40.89%) | (39.20%) | (71.56%) | (200.54%) | (168.97%) | (200.32%) | (97.94%) | |
ROIC |
0.00% | (4,656.25%) | (258.21%) | (629.14%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
700.53% | (6,740.34%) | (2,189.48%) | (87.30%) | (56.91%) | (42.01%) | 159.64% | (1,528.71%) | 382.62% | (238.99%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.11) | (0.01) | (0.15) | (0.19) | (0.22) | (0.12) | (0.25) | (0.07) | (0.14) | (0.16) |
Cash per Share |
0.03 | 0.03 | 0.01 | 0.18 | 0.43 | 0.68 | 0.01 | 0.08 | 0.00 | 0.13 |
Shareholders Equity per Share |
0.00 | 0.04 | 0.05 | 0.19 | 0.42 | 0.64 | (0.20) | 0.01 | (0.04) | 0.09 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 0.04 | 0.05 | 0.19 | 0.42 | 0.64 | (0.20) | 0.01 | (0.04) | 0.09 |
Free Cash Flow |
(12.87) | (1.54) | (15.70) | (19.61) | (21.78) | (11.34) | (6.80) | (4.60) | (7.53) | (6.97) |
Working Capital |
(2.66) | 0.16 | 0.80 | 17.62 | 41.13 | 62.20 | (5.85) | 0.51 | (2.30) | 4.05 |
Capital Expenditures |
(0.02) | (0.02) | — | — | (0.02) | 0.00 | 0.00 | — | 0.00 | (0.05) |
Net Current Asset Value |
(2.89) | 0.16 | 0.69 | 17.38 | 41.13 | 61.91 | (6.39) | 0.51 | (2.30) | 4.05 |
| Other line items | ||||||||||
Quick Ratio |
0.72 | 1.00 | 1.09 | 3.60 | 6.28 | 8.70 | 0.18 | 0.99 | 0.60 | 2.77 |
Depreciation/Fixed assets |
9.00 | 7.75 | 9.60 | 3.00 | 8.29 | 30.33 | 42.17 | 2.29 | 0.57 | 0.31 |
Cash ROIC |
(316.79%) | (20.17%) | (233.64%) | (52.04%) | (26.10%) | (8.82%) | 163.53% | (71.93%) | 421.77% | (68.15%) |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.11) | (0.01) | (0.15) | (0.19) | (0.22) | (0.12) | (0.25) | (0.07) | (0.14) | (0.16) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
3.86 | 4.79 | 5.90 | 5.53 | 4.38 | 2.35 | 1.09 | 1.91 | 1.46 | 0.27 |
Average Payables |
8.85 | 6.81 | 6.46 | 6.36 | 5.89 | 5.99 | 6.18 | 5.35 | 3.45 | 3.45 |
Average Assets |
11.39 | 11.73 | 19.33 | 37.65 | 59.74 | 36.52 | 4.65 | 4.70 | 4.35 | 9.98 |
Average Common Equity |
1.99 | 4.74 | 12.55 | 30.43 | 51.83 | 28.44 | (2.50) | (0.88) | 0.91 | (0.76) |
Capex to Sales |
0.00 | 0.00 | — | — | 0.00 | 0.00 | 0.00 | — | 0.00 | 0.00 |
Columns are period end dates